TP53 and breast cancer: DHODH inhibition by leflunomide induces upregulation of p53 in Hela cells [52], inhibits proliferation of PTEN-mutant human breast cancer cell lines [29, 145], and contributes to RCC S phase arrest and autophagy [49].